This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Ketobemidone: Difference between revisions
>IJUSTPOPPEDAXAN Added basic legal status section |
>IJUSTPOPPEDAXAN Added basic subjective effects |
||
| Line 19: | Line 19: | ||
==Subjective effects== | ==Subjective effects== | ||
* Euphoria | |||
* Confusion | |||
* Sedation | |||
* Dizziness | |||
* Headache | |||
* Blurred vision | |||
* Bradycardia | |||
* Respiratory depression | |||
* Dry mouth | |||
* Nausea | |||
* Vomiting | |||
* Constipation | |||
* Difficulty urinating | |||
* Decreased blood pressure | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
| Line 33: | Line 47: | ||
==Legal status== | ==Legal status== | ||
* '''Australia:''' S9 (Prohibited substance) | *'''Australia:''' S9 (Prohibited substance) | ||
* '''Canada:''' Schedule I | *'''Canada:''' Schedule I | ||
* '''Germany:''' Anlage II (Authorized trade only, not prescriptible) | *'''Germany:''' Anlage II (Authorized trade only, not prescriptible) | ||
* '''United States:''' Schedule I | *'''United States:''' Schedule I | ||
* '''European Union:''' Prescription only<ref>https://www.ema.europa.eu/en/documents/psusa/ketobemidone-list-nationally-authorised-medicinal-products-psusa/0001807/202005_en.pdf</ref> | *'''European Union:''' Prescription only<ref>https://www.ema.europa.eu/en/documents/psusa/ketobemidone-list-nationally-authorised-medicinal-products-psusa/0001807/202005_en.pdf</ref> | ||
==See also== | ==See also== | ||